← Back to Search

Preference Elicitation tool for Carpal Tunnel Syndrome

N/A
Waitlist Available
Led By Robin N Kamal, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of carpal tunnel syndrome
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after using tool
Awards & highlights

Study Summary

This trial will compare two groups of 150 patients each, one treated for carpal tunnel syndrome with a new tool and one treated with standard care. The goal is to see if the new tool decreases patients' decisional conflict.

Eligible Conditions
  • Carpal Tunnel Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with carpal tunnel syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after using tool
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after using tool for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decisional Conflict Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Patients will use a preference elicitation tool to determine their preferences for diagnosis and treatment of CTS
Group II: ControlActive Control1 Intervention
None- normal care

Find a Location

Who is running the clinical trial?

Harvard UniversityOTHER
229 Previous Clinical Trials
474,560 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,878 Total Patients Enrolled
5 Trials studying Carpal Tunnel Syndrome
798 Patients Enrolled for Carpal Tunnel Syndrome
Duke UniversityOTHER
2,351 Previous Clinical Trials
3,409,497 Total Patients Enrolled

Media Library

Preference Elicitation tool Clinical Trial Eligibility Overview. Trial Name: NCT03532373 — N/A
Preference Elicitation tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT03532373 — N/A
Carpal Tunnel Syndrome Clinical Trial 2023: Preference Elicitation tool Highlights & Side Effects. Trial Name: NCT03532373 — N/A
Carpal Tunnel Syndrome Research Study Groups: Control, Intervention

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing recruitment opportunities for this research endeavor?

"The clinicaltrials.gov registry shows that this study, which was first announced on March 1st 2021 and last updated four months ago, is not presently recruiting patients. However, there are currently 1404 other trials actively searching for participants to enroll in their research programs."

Answered by AI
~12 spots leftby Mar 2025